StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
109
This month
3
This year
13
Publishing Date
2024 - 03 - 06
2
2024 - 01 - 04
2
2023 - 05 - 03
2
2022 - 11 - 02
1
2022 - 10 - 20
2
2022 - 09 - 23
1
2022 - 09 - 15
1
2022 - 09 - 08
1
2022 - 09 - 05
1
2022 - 08 - 23
1
2022 - 08 - 01
1
2022 - 07 - 28
1
2022 - 07 - 21
1
2022 - 06 - 23
1
2022 - 06 - 03
1
2022 - 05 - 11
1
2022 - 05 - 10
1
2022 - 05 - 03
1
2022 - 04 - 29
1
2022 - 04 - 08
1
2022 - 04 - 05
1
2022 - 03 - 24
1
2022 - 03 - 17
1
2022 - 02 - 04
1
2022 - 01 - 24
1
2022 - 01 - 05
1
2022 - 01 - 04
1
2021 - 12 - 16
1
2021 - 12 - 09
1
2021 - 12 - 02
1
2021 - 11 - 24
1
2021 - 11 - 16
1
2021 - 11 - 09
1
2021 - 10 - 26
1
2021 - 10 - 15
1
2021 - 09 - 23
1
2021 - 09 - 17
1
2021 - 09 - 15
1
2021 - 09 - 07
1
2021 - 09 - 02
1
2021 - 08 - 30
2
2021 - 08 - 11
1
2021 - 07 - 12
1
2021 - 07 - 06
1
2021 - 06 - 22
1
2021 - 06 - 16
1
2021 - 06 - 14
1
2021 - 06 - 10
1
2021 - 06 - 09
2
2021 - 05 - 28
1
2021 - 05 - 25
1
2021 - 05 - 12
1
2021 - 05 - 11
1
2021 - 05 - 04
1
2021 - 04 - 28
1
2021 - 04 - 21
1
2021 - 04 - 19
1
2021 - 03 - 18
2
2021 - 03 - 16
1
2021 - 01 - 05
1
Sector
Finance
6
Finance and insurance
4
Health technology
109
Manufacturing
1
Tags
Aml
1
Antibody
2
Asco
1
Blood
1
Business
8
Cancer
4
Candidate
2
Cell
3
Change
1
Clearance
1
Clinical-trials-phase-ii
5
Clinical-trials-phase-iii
2
Collaboration
2
Conference
27
Covid
1
Covid-19
1
Designation
1
Disease
1
Drug
4
Earnings
10
Europe
13
Events
24
Expansion
2
Fast track designation
1
Fda
2
Financial
11
Financial results
4
First
1
Growth
1
Iph45
2
Iph5201
2
Iph6101
4
Iph6401
1
Iph6501
1
License
1
Market
1
Meeting
1
Money
2
N/a
27
Natural
2
News
1
Ongoing
1
Payment
1
Pharma
96
Pharmaceutical
15
Phase 2
5
Platform
2
Preclinical
2
Presentation
3
Program
3
Regulatory
5
Report
5
Research
3
Results
18
Sanofi
6
Study
3
Trial
10
Universal
2
Update
15
Year
4
Entities
Abbott laboratories
251
Abbvie inc.
211
Alnylam pharmaceuticals, inc.
78
Alphabet inc.
32
Amarin corporation plc
31
Amgen inc.
170
Astellas pharma inc
70
Astrazeneca plc
213
Aveo pharmaceuticals, inc.
20
Bausch health companies inc.
30
Baxter international inc.
45
Becton, dickinson and company
34
Biogen inc.
53
Biomarin pharmaceutical inc.
29
Biontech se
167
Blueprint medicines corporation
20
Boston scientific corporation
25
Bristol-myers squibb company
119
Byline bancorp, inc.
26
Clovis oncology, inc.
20
Csl ltd
22
Denali therapeutics inc.
22
Eli lilly and company
335
Endo international plc
20
Galapagos nv
36
Gilead sciences, inc.
64
Glaxosmithkline plc
334
Igm biosciences, inc.
37
Incyte corporation
121
Innate pharma s.a.
109
Innate pharma sa
81
Johnson & johnson
571
Karyopharm therapeutics inc.
25
Kymera therapeutics, inc.
29
Ligand pharmaceuticals incorporated
20
Medtronic plc
45
Mobiv acquisition corp
65
Moderna, inc.
34
Morphosys ag
36
Nektar therapeutics
43
Novartis ag
329
Novo nordisk a/s
139
Oncocyte corporation
32
Orange
49
Perrigo company
111
Pfizer, inc.
153
Provention bio, inc.
283
Ptc therapeutics, inc.
32
Rallybio corp
31
Rcf acquisition corp.
83
Regeneron pharmaceuticals, inc.
254
Sanofi
4539
Takeda pharmaceutical company limited
60
Teva pharmaceutical industries ltd
224
Therapeuticsmd, inc.
31
Thermo fisher scientific inc
43
Translate bio, inc.
21
Vaxart, inc.
33
Viatris inc.
87
Vir biotechnology, inc.
22
Symbols
ABBV
1
ALPMF
1
ALPMY
1
AMGN
1
ARGX
1
AZN
4
AZNCF
1
BIIB
1
BMY
2
BNPQF
4
BNPQY
4
DNLI
1
GLAXF
1
GSK
1
INCY
1
IPHA
120
IPHYF
80
JNJ
1
LLY
1
MS
1
NVO
71
NVS
1
NVSEF
1
SIVB
1
SNY
109
SNYNF
81
TAK
2
TEVJF
1
VRTX
1
ZLAB
1
Exchanges
Nasdaq
109
Nyse
73
Crawled Date
2024 - 03 - 06
2
2024 - 01 - 04
2
2023 - 05 - 03
2
2022 - 11 - 02
1
2022 - 10 - 20
2
2022 - 09 - 23
1
2022 - 09 - 15
1
2022 - 09 - 08
1
2022 - 09 - 05
1
2022 - 08 - 23
1
2022 - 08 - 01
1
2022 - 07 - 28
1
2022 - 07 - 21
1
2022 - 06 - 23
1
2022 - 06 - 03
1
2022 - 05 - 11
1
2022 - 05 - 10
1
2022 - 05 - 03
1
2022 - 04 - 29
1
2022 - 04 - 08
1
2022 - 04 - 05
1
2022 - 03 - 24
1
2022 - 03 - 17
1
2022 - 02 - 04
1
2022 - 01 - 24
1
2022 - 01 - 05
1
2022 - 01 - 04
1
2021 - 12 - 16
1
2021 - 12 - 09
1
2021 - 12 - 02
1
2021 - 11 - 24
1
2021 - 11 - 16
1
2021 - 11 - 09
1
2021 - 10 - 26
1
2021 - 10 - 15
1
2021 - 09 - 23
1
2021 - 09 - 17
1
2021 - 09 - 15
1
2021 - 09 - 07
1
2021 - 09 - 02
1
2021 - 08 - 30
2
2021 - 08 - 11
1
2021 - 07 - 12
1
2021 - 07 - 06
1
2021 - 06 - 22
1
2021 - 06 - 16
1
2021 - 06 - 14
1
2021 - 06 - 10
1
2021 - 06 - 09
2
2021 - 05 - 28
1
2021 - 05 - 25
1
2021 - 05 - 12
1
2021 - 05 - 11
1
2021 - 05 - 04
1
2021 - 04 - 28
1
2021 - 04 - 21
1
2021 - 04 - 19
1
2021 - 03 - 18
2
2021 - 03 - 16
1
2021 - 01 - 05
1
Crawled Time
05:00
2
06:00
22
07:00
22
08:00
19
09:00
18
10:00
8
11:00
10
12:00
5
12:30
1
22:00
1
23:00
1
Source
www.biospace.com
82
www.globenewswire.com
26
www.prnewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Innate pharma s.a.
symbols :
Sny
save search
Innate Pharma Presents at AACR 2024 Preclinical Efficacy of Its Pre-IND Drug Candidate IPH45, a Novel Nectin-4 Antibody Drug Conjugate
Published:
2024-04-10
(Crawled : 09:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-1.65%
|
O:
-0.01%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-2.59%
|
O:
-0.32%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
-6.15%
|
O:
-3.85%
H:
1.2%
C:
0.8%
iph45
pharma
drug
candidate
antibody
preclinical
Innate Pharma Announces Its Participation in Upcoming April 2024 Investor Conference
Published:
2024-04-09
(Crawled : 09:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-1.38%
|
O:
0.28%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-2.16%
|
O:
-0.38%
H:
0.95%
C:
0.83%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
-2.01%
|
O:
2.57%
H:
1.81%
C:
1.81%
pharma
conference
Innate Pharma Files Its 2023 Universal Registration Document (Document d’enregistrement Universel) and 2023 Annual Report on Form 20-F
Published:
2024-04-05
(Crawled : 11:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-3.54%
|
O:
-1.77%
H:
0.0%
C:
-1.81%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.72%
|
O:
-3.44%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
-2.4%
|
O:
-0.4%
H:
0.0%
C:
-5.22%
pharma
report
universal
Innate Pharma Reports Full Year 2023 Financial Results and Business Update
Published:
2024-03-21
(Crawled : 09:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-2.29%
|
O:
0.14%
H:
0.24%
C:
0.24%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-2.16%
|
O:
0.3%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
-2.4%
|
O:
-4.51%
H:
4.25%
C:
0.96%
pharma
business
year
update
financial
results
Innate Pharma Announces Its Participation to Upcoming Investor Conference - March 19, 2024
Published:
2024-03-19
(Crawled : 08:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-2.31%
|
O:
-0.02%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-3.6%
|
O:
-1.51%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
2.09%
|
O:
0.84%
H:
4.56%
C:
0.83%
pharma
conference
Innate Pharma Announces Conference Call and Webcast for Full Year 2023 Financial Results
Published:
2024-03-14
(Crawled : 09:00)
- biospace.com/
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.18%
|
O:
0.23%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
-2.4%
|
O:
-2.4%
H:
3.69%
C:
3.28%
pharma
conference
year
financial
results
Innate Pharma: First Patient dosed in Phase 1/2 study of IPH6501 in relapsed /refractory B-Cell non-Hodgkin’s Lymphoma
Published:
2024-03-06
(Crawled : 12:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-1.01%
|
O:
0.0%
H:
0.8%
C:
0.8%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-2.63%
|
O:
-0.45%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
-5.06%
|
O:
0.78%
H:
1.93%
C:
0.97%
iph6501
first
study
Innate Pharma to Present Nectin-4 Antibody Drug Conjugate IPH45 Preclinical Data at AACR 2024
Published:
2024-03-06
(Crawled : 11:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-1.01%
|
O:
0.0%
H:
0.8%
C:
0.8%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-2.63%
|
O:
-0.45%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
-5.06%
|
O:
0.78%
H:
1.93%
C:
0.97%
iph45
pharma
drug
antibody
preclinical
Innate Pharma Announces Its Participation to Upcoming March 2024 Investor Conference
Published:
2024-02-21
(Crawled : 07:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-1.49%
|
O:
1.7%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-2.32%
|
O:
-0.57%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
-5.79%
|
O:
-2.32%
H:
0.0%
C:
0.0%
pharma
conference
Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published:
2024-02-12
(Crawled : 23:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
-1.6%
|
O:
3.52%
H:
0.0%
C:
-1.18%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
12.87%
|
O:
0.06%
H:
2.34%
C:
2.29%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-12.2%
|
O:
0.37%
H:
0.74%
C:
0.28%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-7.48%
|
O:
0.14%
H:
0.35%
C:
0.07%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-6.14%
|
O:
-0.34%
H:
0.23%
C:
-1.13%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-5.55%
|
O:
0.7%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-3.21%
|
O:
1.22%
H:
0.07%
C:
-0.43%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-1.49%
|
O:
-0.96%
H:
1.75%
C:
1.75%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-1.65%
|
O:
-0.18%
H:
0.48%
C:
-1.91%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-3.85%
|
O:
0.8%
H:
0.0%
C:
0.0%
ZLAB
|
$14.08
-0.99%
-0.99%
470K
|
Health Technology
|
-22.73%
|
O:
-1.15%
H:
1.03%
C:
-1.5%
VRTX
|
News
|
$394.43
0.24%
0.24%
1.3M
|
Health Technology
|
-5.79%
|
O:
-0.28%
H:
0.49%
C:
-0.32%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
0.22%
|
O:
-0.06%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
-5.43%
|
O:
-3.1%
H:
1.2%
C:
-0.8%
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
-9.49%
|
O:
3.8%
H:
1.1%
C:
-1.17%
BIIB
|
$194.39
2.03%
1.99%
1.6M
|
Health Technology
|
-20.58%
|
O:
-3.72%
H:
0.58%
C:
-3.82%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
11.63%
|
O:
-0.26%
H:
0.73%
C:
-0.36%
ARGX
|
$360.11
0.47%
0.47%
330K
|
Health Technology
|
-8.27%
|
O:
-2.3%
H:
1.65%
C:
0.83%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-8.66%
|
O:
0.06%
H:
0.31%
C:
-1.4%
expansion
growth
market
Number of Shares and Voting Rights of Innate Pharma as of January 1, 2024
Published:
2024-01-12
(Crawled : 11:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-11.92%
|
O:
0.71%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-11.54%
|
O:
0.06%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
-12.54%
|
O:
0.0%
H:
0.36%
C:
0.36%
pharma
Innate Pharma Strengthens Leadership and Appoints Two New Members to Its Executive Board
Published:
2024-01-04
(Crawled : 09:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-7.51%
|
O:
1.62%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-7.51%
|
O:
1.12%
H:
0.93%
C:
0.77%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
-12.23%
|
O:
6.47%
H:
3.65%
C:
-2.36%
pharma
Innate Pharma Announces U.S. FDA Lifts Partial Clinical Hold on Lacutamab Clinical Program
Published:
2024-01-04
(Crawled : 08:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-7.51%
|
O:
1.62%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-7.51%
|
O:
1.12%
H:
0.93%
C:
0.77%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
-12.23%
|
O:
6.47%
H:
3.65%
C:
-2.36%
fda
pharma
program
Innate Pharma Announces Licensing of a Fourth Natural Killer Cell Engager in Oncology to Sanofi
Published:
2023-12-19
(Crawled : 08:00)
- biospace.com/
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
23.97%
|
O:
0.91%
H:
0.72%
C:
0.11%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.44%
|
O:
0.45%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
-0.41%
|
O:
13.88%
H:
0.0%
C:
-3.58%
pharma
natural
cell
sanofi
Innate Pharma Announces Leadership Change - December 18, 2023
Published:
2023-12-18
(Crawled : 10:00)
- biospace.com/
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-3.24%
|
O:
1.25%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
1.24%
|
O:
2.9%
H:
2.02%
C:
-1.21%
pharma
change
Innate Pharma Shares Efficacy and Safety Phase 1 /2 Results of NK Cell Engager SAR443579 / IPH6101 Developed by Sanofi at ASH 2023
Published:
2023-12-11
(Crawled : 08:00)
- biospace.com/
IPHYF
|
$2.65
104.6%
300
|
Health Technology
|
11.81%
|
O:
9.45%
H:
0.0%
C:
-1.7%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-0.54%
|
O:
0.5%
H:
1.67%
C:
0.1%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
0.19%
|
O:
2.15%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
-5.43%
|
O:
-1.16%
H:
0.39%
C:
-4.31%
sar4435
pharma
iph6101
cell
results
sanofi
Innate Pharma to Host Virtual KOL Event on Lacutamab
Published:
2023-11-27
(Crawled : 11:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-2.62%
|
O:
-0.36%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-1.72%
|
O:
1.04%
H:
0.17%
C:
0.11%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
0.83%
|
O:
2.07%
H:
1.21%
C:
1.21%
pharma
Innate Pharma Reports Third Quarter 2023 Financial Results and Business Update
Published:
2023-11-14
(Crawled : 09:00)
- biospace.com/
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
2.03%
|
O:
0.68%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
7.49%
|
O:
6.61%
H:
9.39%
C:
6.61%
pharma
business
update
financial
results
Innate Pharma Announces Conference Call for Third Quarter 2023 Business Update
Published:
2023-11-07
(Crawled : 08:00)
- biospace.com/
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
1.37%
|
O:
-1.32%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
-6.15%
|
O:
-2.31%
H:
2.76%
C:
1.18%
pharma
conference
business
update
Innate Pharma Announces Its Participation to Upcoming November 2023 Investor Conferences
Published:
2023-10-27
(Crawled : 08:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-11.93%
|
O:
-18.18%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-12.87%
|
O:
-15.73%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
-0.81%
|
O:
-2.85%
H:
12.13%
C:
3.77%
pharma
← Previous
1
2
3
4
5
6
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
GBR
|
$1.42
31.48%
11.27%
990K
|
Energy Minerals
KUKE
|
$2.88
2.49%
7.64%
360K
|
CXM
4
|
$11.34
-0.44%
4.27%
1.7M
|
Information
PVL
4
|
$1.47
-0.68%
4.08%
77K
|
Energy Minerals
RNR
4
|
$224.74
0.85%
3.52%
310K
|
Finance
BSBR
|
$5.25
2.54%
0.38%
430K
|
Finance
DV
|
News
|
$29.43
-2.36%
0.24%
1.9M
|
Information
JOE
4
|
$54.88
1.22%
0.22%
210K
|
Finance
JEF
4
|
$42.17
1.57%
0.07%
1.8M
|
Finance
MUSA
4
|
$417.23
1.06%
0.01%
170K
|
Retail Trade
Your saved searches
Save your searches and get alerts when important news are released.